A cold sore is a cluster of small, fluid-filled blisters that typically appears on or around the lips, caused by herpes simplex virus type 1 (HSV-1). If you have a tingling or burning patch near your mouth that turns into grouped blisters, weeps, and then crusts over within about a week, you are almost certainly looking at a cold sore. But the picture is not always that textbook-clear, and the stages leading up to and following those blisters matter for both identification and treatment timing.
What a Cold Sore Looks Like at Each Stage
Cold sores progress through a recognizable sequence that usually plays out over seven to ten days, though some outbreaks stretch to two weeks. Knowing where you are in this sequence tells you what to expect next and when treatment is most useful.
- Prodrome (day 1): Before anything is visible, you feel a tingling, itching, or burning sensation on a small area of your lip or the skin around your mouth. The spot may feel slightly swollen or tight. This stage is easy to dismiss as chapped skin, but it is the single best window for starting antiviral treatment.
- Blister formation (days 2–3): A cluster of tiny, fluid-filled vesicles appears. They often group together on one side of the lip border, though they can also show up just below the nose, on the chin, or inside the nostrils. The blisters are usually painful and surrounded by red, inflamed skin.
- Ulceration (days 3–4): The blisters rupture, merge, and form a shallow, weeping sore. This is the most contagious stage and typically the most uncomfortable. The exposed tissue is raw and easily irritated by food, toothpaste, or sun.
- Crusting (days 5–8): A yellowish or brownish crust forms over the sore. The crust may crack and bleed if the area is stretched by talking or eating. Underneath, new skin is forming.
- Healing (days 8–10+): The crust falls off, revealing pink or slightly discolored new skin. Scarring is uncommon unless the sore was picked at or became secondarily infected with bacteria.
Not every outbreak follows this timeline precisely. Some people experience what is called an “aborted” episode: they feel the prodromal tingling, and maybe a small bump forms, but a full blister never develops. This is more common in people who start antiviral medication during the prodrome or in those whose immune systems suppress the virus quickly on their own.
Is It Actually a Cold Sore or Something Else?
Several other conditions show up on or near the lips and can be mistaken for a cold sore, especially during the early or late stages when the characteristic blister cluster may not be obvious.
- Canker sores: These are shallow, round ulcers that appear inside the mouth, on the tongue, inner cheeks, or soft palate. They are not caused by a virus and are not contagious. The key difference is location: canker sores are almost always inside the mouth, while cold sores are almost always on the outer lip or surrounding skin.
- Angular cheilitis: Cracking and redness at the corners of the mouth, usually caused by a fungal or bacterial infection. It does not form blisters and tends to affect both corners symmetrically.
- Contact dermatitis: An allergic reaction to lip balm, toothpaste, or cosmetics can cause swelling, redness, and even small blisters on the lips. The distribution is usually more diffuse than a cold sore cluster, and there is no prodromal tingle.
- Impetigo: A bacterial skin infection that produces honey-colored crusts. It can look similar to a crusting cold sore but often spreads to other areas of the face and responds to antibiotics rather than antivirals.
If you are unsure, a doctor or pharmacist can often tell the difference on sight. For cases that are ambiguous, a swab test can detect HSV DNA and give a definitive answer.
Why Cold Sores Keep Coming Back
Once HSV-1 infects you, it never leaves. After the initial infection, the virus travels along nerve fibers and settles into clusters of nerve cells called the trigeminal ganglia, near the base of the skull. There it stays in a dormant state, maintained by a constant low-level immune response. Research on post-mortem human tissue has found that immune cells, particularly certain T cells and macrophages, are consistently present in nerve tissue harboring latent HSV-1, producing inflammatory signals that keep the virus in check.1PubMed Central. Latent herpesvirus infection in human trigeminal ganglia causes chronic immune response The virus has evolved to coexist with this surveillance, and when the balance tips, it reactivates, travels back down the nerve, and produces a new outbreak on the skin the nerve supplies.
Most people pick up HSV-1 during childhood or adolescence. Estimates suggest that roughly 70% of people in Western countries are infected by their early twenties, often through casual contact like a kiss from a family member.2PubMed Central. Herpes simplex virus: an occupational hazard in dentistry The initial infection may produce a noticeable mouth sore, or it may pass with such mild symptoms that you never realize it happened. Either way, the virus establishes latency, and for some people that means recurrent cold sores for years or decades.
Common Triggers for an Outbreak
Not everyone who carries HSV-1 gets frequent cold sores. Some people have one outbreak every few years; others deal with them monthly. The difference depends partly on the individual’s immune control of the virus and partly on what triggers reactivation. A review of clinical evidence identifies several well-documented triggers: psychological stress and anxiety, exposure to ultraviolet light (sunburn, tanning beds, or even extended time outdoors), fever or systemic illness, hormonal shifts such as menstruation, and physical trauma to the lip area like dental work or windburn.3PubMed Central. Anxiety and Sun Exposure as Triggers for Herpes Labialis: A Case Report and Review of Literature Research into how the virus escapes latency points to stress and sunlight as particularly reliable provocateurs, because both can suppress the local immune response that normally keeps the virus dormant in neurons.4BioEssays. ICP0, a regulator of herpes simplex virus during lytic and latent infection
If you notice a pattern in your outbreaks, adjusting for it can help. Wearing SPF lip balm year-round is one of the simpler preventive moves. Managing stress is easier said than done, but people who track their cold sores often notice a link between high-pressure weeks and the prodromal tingle. Recognizing your personal triggers gives you an early-warning system to start treatment faster.
How Cold Sores Spread, Even When You Cannot See One
Cold sores are contagious, and not just during the blister stage. A study tracking HSV-1 shedding in healthy adults found that the virus was detectable in the oral mucosa on about a quarter of all days sampled, and the vast majority of that shedding happened when participants had no visible lesion at all.5PubMed Central. Herpes Simplex Virus Type 1 Shedding in Tears, and Nasal and Oral Mucosa of Healthy Adults On days with active lesions, the shedding rate was higher (about 36%), but those days accounted for only a small fraction of total shedding events. Over 94% of the days when the virus was detected were days without symptoms. That means the virus is quietly present on the lips and inside the mouth far more often than most people realize.
This asymptomatic shedding is why cold sores are so widespread. You can transmit HSV-1 through kissing, sharing utensils, or other close contact even when your lips look and feel perfectly normal. The practical takeaway is that avoiding contact only during visible outbreaks is not a complete prevention strategy, especially around people who are at higher risk from the virus, like newborns or people with weakened immune systems.
What to Do When You Feel One Coming
Speed matters more than almost anything else when treating a cold sore. The goal is to catch it during the prodromal stage, before blisters form.
Prescription antivirals are the most effective option. Valacyclovir (Valtrex) taken as a high-dose, one-day regimen at the first sign of tingling shortened the average cold sore episode by about a day compared to placebo in two large trials, and in a meaningful portion of patients it prevented the sore from fully developing.6PubMed Central. High-dose, short-duration, early valacyclovir therapy for episodic treatment of cold sores: results of two randomized, placebo-controlled, multicenter studies A day might not sound like much, but when you are dealing with a painful, visible sore on your face, even a modest reduction in duration is welcome. Separate trial data on recurrent herpes episodes confirmed that patients who started treatment within six hours of the first symptom saw faster resolution than those who waited a full day.7Archives of Dermatology. A Randomized, Placebo-Controlled Comparison of Oral Valacyclovir and Acyclovir in Immunocompetent Patients With Recurrent Genital Herpes Infections Acyclovir (Zovirax) works by the same mechanism and performs comparably; the main advantage of valacyclovir is convenience, since its dosing schedule is simpler.
If you get cold sores frequently, ask your doctor about keeping a prescription on hand so you can start treatment the moment you feel the tingle, rather than waiting for a clinic appointment.
Over-the-Counter Options and Cold Sore Patches
Docosanol cream (sold as Abreva in the United States) is the main over-the-counter antiviral for cold sores. It works differently from prescription antivirals: rather than targeting the virus’s replication machinery, it helps prevent the virus from fusing with healthy cell membranes. The effect is modest, typically shortening an outbreak by less than a day, and it needs to be applied five times daily starting at the prodrome.
Hydrocolloid cold sore patches are a newer option that has gained popularity. These thin, adhesive patches cover the sore, keep it moist, protect it from contamination, and conceal it cosmetically. A randomized trial found that a hydrocolloid patch performed comparably to acyclovir cream across all stages of a cold sore outbreak, while offering the added benefits of wound protection and discretion.8PubMed. Randomized clinical study comparing Compeed cold sore patch to acyclovir cream 5% in the treatment of herpes simplex labialis Patches do not contain an antiviral agent, so they are not fighting the virus directly. Instead, they create an environment that supports faster wound healing and reduces the chances of cracking and bacterial superinfection. For people who dislike applying cream throughout the day or want something less visible, a patch can be a reasonable choice, though combining a patch with an oral antiviral is probably the best of both worlds.
Pain relief during an active sore can come from over-the-counter numbing agents containing benzocaine or lidocaine, or simply from applying ice wrapped in a cloth. Ibuprofen or acetaminophen helps with the aching and inflammation.
What About Lysine?
L-lysine supplements are one of the most commonly recommended home remedies for cold sores, especially online. The idea is that lysine competes with arginine, an amino acid that HSV needs to replicate. The evidence, however, is mixed and not especially strong. A review of the available data concluded that doses under 1 gram per day appeared ineffective for either preventing or treating cold sores, while doses above 3 grams per day seemed to improve how patients rated their symptoms, though without strong objective confirmation.9PubMed Central. Lysine for Herpes Simplex Prophylaxis: A Review of the Evidence A separate long-term pilot study following patients over eight years reported that participants using lysine experienced fewer recurrences and some had lesions that stalled in the prodromal phase without progressing to full blisters.10Revista Gaúcha de Odontologia. The effect of L-Lysine in recurrent herpes labialis: pilot study with a 8-year follow up
Lysine is unlikely to harm you at reasonable doses, and some people swear by it. But if you are relying on lysine alone to manage frequent outbreaks, the evidence suggests you would be better served adding a prescription antiviral to your toolkit. Think of lysine as a supplement that might nudge things in the right direction, not as a substitute for proven treatment.
When a Cold Sore Becomes Dangerous
For most healthy adults, cold sores are a nuisance, not a danger. But there are situations where HSV-1 can cause serious harm.
People with atopic dermatitis (eczema) are at risk for a complication called eczema herpeticum, where HSV spreads across large areas of inflamed skin. This shows up as a sudden eruption of dome-shaped blisters and pustules within eczematous patches, often accompanied by fever and feeling severely unwell.11Journal of the American Academy of Dermatology. Predisposing factors and clinical features of eczema herpeticum: a retrospective analysis of 100 cases It occurs in roughly 3% of people with atopic dermatitis, and it can be life-threatening if untreated, requiring intravenous antivirals and sometimes hospitalization.12PubMed. Eczema Herpeticum: Clinical and Pathophysiological Aspects If you or your child have eczema and develop a rapidly spreading, painful, blistery rash that looks different from a typical eczema flare, seek medical attention urgently.
Newborns are another high-risk group. Neonatal herpes is rare but potentially devastating, and it can be acquired not just during birth but through postnatal contact such as a kiss from someone shedding the virus. A review of neonatal HSV exposure notes that while many infants are protected by antibodies passed from their mother during pregnancy, babies born to mothers who have never been infected with HSV lack this protection and are more vulnerable.13The Pediatric Infectious Disease Journal. Postnatal Exposure to Herpes Simplex Virus: To Treat or Not to Treat? The straightforward precaution: do not kiss newborns on or near the mouth, and be especially cautious if you have a history of cold sores, even if you do not have an active one at the time.
HSV-1 can also affect the eyes if the virus is transferred there, usually by touching a cold sore and then rubbing your eye. Herpes keratitis is a leading infectious cause of corneal blindness in developed countries. Washing your hands after touching an active sore is not overly cautious; it is genuinely important.
The Shifting Line Between HSV-1 and HSV-2
Cold sores are overwhelmingly associated with HSV-1, and genital herpes with HSV-2, but that division is less neat than it used to be. Over the past few decades, HSV-1 has become a leading cause of first-episode genital herpes in high-income countries, particularly among adolescents and young adults.14PubMed. From HSV-2 to HSV-1: A change in the epidemiology of genital herpes The shift appears to be driven by declining rates of childhood HSV-1 infection: when fewer people pick up the virus as children (through casual family contact), more reach adolescence without any antibodies, leaving them susceptible to genital infection through oral sex. Epidemiological data from a dermatology hospital in southern China confirmed that HSV-1 detection has been rising over recent years while HSV-2 has been declining, and that HSV-1 infections are predominantly oral and facial while HSV-2 remains concentrated in the anogenital region.15PubMed. Epidemiological Trends of Herpes Simplex Virus (HSV-1 and HSV-2) Infections: A Six-Year Analysis From a Dermatology Hospital in Southern China (2019-2024)
For a reader wondering “is this a cold sore?”, the practical implication is this: a cold sore on the lip is almost always HSV-1, but the same virus can also cause sores in the genital area if transmitted there. Having cold sores does not mean you have genital herpes, and having genital herpes caused by HSV-1 does not mean you will get frequent recurrences in that location. HSV-1 genital outbreaks tend to recur far less often than HSV-2 genital outbreaks.
Emerging Treatments on the Horizon
For most people, existing antivirals work well enough, but they are not perfect, and for immunocompromised patients whose virus has developed resistance to standard drugs, options have been limited. A new antiviral called pritelivir, which blocks the virus through a different mechanism than acyclovir-class drugs, is showing promise. In a recent randomized trial of immunocompromised adults with acyclovir-resistant HSV, pritelivir achieved an investigator-assessed healing rate of 93% compared to 57% for foscarnet (the traditional backup drug), with fewer serious side effects.16PubMed Central. Efficacy and Safety of Pritelivir vs Foscarnet for the Treatment of Acyclovir-Refractory Herpes Simplex Virus Infection in Immunocompromised Adults: A Randomized, Open-Label Phase 2 Trial Pritelivir is not yet widely available and is currently being studied for broader populations, but it represents a genuinely new class of anti-herpes drug for the first time in decades.
Vaccine development is another area of active research, though no HSV vaccine has yet made it to market despite decades of effort. The challenge is that the virus’s ability to hide in nerve tissue and evade the immune system makes it a difficult target. Several candidates are in clinical trials, including both therapeutic vaccines (aimed at reducing recurrences in people who already carry the virus) and prophylactic vaccines (aimed at preventing infection altogether). For now, the cold sore toolkit remains centered on existing antivirals and trigger management, but the pipeline is more active than it has been in years.